New technologies in using recombinant attenuated Salmonella vaccine vectors. - sprookjes - yvandenbroek - TriplyDB

New technologies in using recombinant attenuated Salmonella vaccine vectors.

New technologies in using recombinant attenuated Salmonella vaccine vectors.

http://www.wikidata.org/entity/Q37674803

about

Salmonella as a vaccine delivery vehicle Immunology of Gut Mucosal Vaccines Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model Immunity to intestinal pathogens: lessons learned from Salmonella The delicate balance in genetically engineering live vaccines.Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague Development of Streptococcus pneumoniae Vaccines Using Live Vectors Development of a Fur-dependent and tightly regulated expression system in Escherichia coli for toxic protein synthesis.Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity.Live bacterial vaccine vectors: an overview.Characterization of the Salmonella enterica serovar Typhimurium ydcI gene, which encodes a conserved DNA binding protein required for full acid stress resistance.Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.Iron-regulated lysis of recombinant Escherichia coli in host releases protective antigen and confers biological containment Use of Ensure® nutrition shakes as an alternative formulation method for live recombinant Attenuated Salmonella Typhi vaccines.Generation of influenza virus from avian cells infected by Salmonella carrying the viral genome Infection with Salmonella enterica Serovar Typhimurium Leads to Increased Proportions of F4/80+ Red Pulp Macrophages and Decreased Proportions of B and T Lymphocytes in the Spleen.Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine Turning self-destructing Salmonella into a universal DNA vaccine delivery platform.New technologies in developing recombinant attenuated Salmonella vaccine vectors.Engineering the type III secretion system in non-replicating bacterial minicells for antigen delivery.Attenuating gene expression (AGE) for vaccine development A colanic acid operon deletion mutation enhances induction of early antibody responses by live attenuated Salmonella vaccine strains.Recombinant vaccines and the development of new vaccine strategies.Rapid, sensitive recovery of recombinant attenuated Salmonella enterica serovar Typhi vaccine strains from human blood.Regulatory T-cell vaccination independent of auto-antigen.Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by co-expression of λ phage holin-endolysin and ɸX174 gene E.Salmonella enterica as a vaccine carrier.Recent progress toward development of vaccines against conception.Optimizing Salmonella enterica serovar Typhimurium for bacteria-mediated tumor therapy.Plague Vaccines: Status and Future.A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge aroA-Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant.Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates.Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV-1 polyepitope CTL immunogen.Salmonella expressing detoxified lipopolysaccharide is immunogenic and protective both as an attenuated vaccine and for delivery of foreign antigens.Multicopy integration of mini-Tn7 transposons into selected chromosomal sites of a Salmonella vaccine strain.Different approaches to expressing Edwardsiella tarda antigen GAPDH in attenuated Vibrio anguillarum for multivalent fish vaccines.

P2860

Q27011946-C9DCDDAA-32C5-4D93-86AA-2BB2425FE1B4 Q28972559-E3D4C567-F6F3-4E11-A9C0-B501D18A3D24 Q33710976-482017A6-E715-40AC-9523-34FD37D0B994 Q33788711-B42983BF-0646-4340-85A0-2D5D86B5EEA0 Q33801051-5587F78E-66D7-4F80-B666-D1AA5E53E04E Q33834427-A9A0684E-84E7-493D-A4C6-5599150800B6 Q34316015-E80DEB25-016A-4CF1-B00F-EB3C6388310C Q34627454-31BAC561-A563-4DE9-A10E-E53EA0E185DC Q35059006-D21525D9-BFE0-4AC5-B333-3BEDCF5A7CCC Q35068970-3E67F763-F370-405B-8C59-91B66B5A75E1 Q35095948-2F0D305E-DA7F-4946-A22F-65C4FCB1644F Q35273125-AA82CE1D-8D62-43F6-889B-911F5BCDAFE6 Q35329206-F8FDE349-3373-46ED-A4D6-E3CE908467D2 Q35338804-9F800D2F-7F17-41D3-928B-468D9787889C Q35572130-A8237F1D-0FAC-41B3-887B-1F99D81516D8 Q35661763-93EDD73D-8AD7-4962-A7BD-5D7699C8A458 Q35689514-E0109D50-8B41-4777-ACC2-B6C8EAE41734 Q35689518-5F91FF9E-3C57-41B7-8A20-D79AB74189D2 Q36277335-0F5BE3B5-E89E-44D1-B741-3EB764552331 Q36436730-4F0A0B45-B4B1-4D47-8C0C-9F4170D2E9C5 Q36653379-B53598B1-ED21-4CFC-AF77-5CAAA15582A6 Q36957667-60A35676-11E0-49AD-8E83-A8F02EC3D13F Q37021492-17CEEAB1-F416-4F98-B405-A977931C4946 Q37123734-E5B1AB61-E768-4DCC-AA44-166A6704B7B9 Q37370940-737ACF86-0B44-45D1-A147-D6BA7A300252 Q37469650-EA4A8A4B-AF35-4947-931E-6B914E2BBF27 Q37679455-9A4CB431-4777-4425-9F8A-ADB7FD8922D1 Q37717154-E641ACF6-0195-4AD7-94A3-A939DE48F98D Q37970705-B3CF5496-15AA-4541-AFE7-FBF88129B7AB Q38168910-9773F67D-4992-4759-9C82-35C70D2D2140 Q38759314-9684F2FE-A7BA-4507-AB1A-EB59434F71E6 Q38813137-CD1C2C70-303F-4461-93A4-FE9259EA725D Q39015820-630840CC-F0B7-4EC0-B2E4-9C0ED88CACDF Q40548549-6CA4134F-CA39-4A72-BDF8-72916EAD2FC2 Q40549367-70ACFE19-945E-46B5-A2EE-CE940C1E4214 Q41418787-41B85D43-D2A5-4666-8A8B-F61FCFB1F29D Q41834074-7911F499-C480-48BA-BC1D-BEAEB9919108 Q41908579-D4F69E2E-8DF3-4DB0-B158-981D64F6E52F Q43135801-E601E3F2-952D-469E-8B6A-F75F8BCEDB78 Q43406367-8092339B-7051-490D-9901-940AE9745EA0

P2860

New technologies in using recombinant attenuated Salmonella vaccine vectors.

http://www.wikidata.org/entity/Q37674803

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New technologies in using recombinant attenuated Salmonella vaccine vectors.

@en

New technologies in using recombinant attenuated Salmonella vaccine vectors.

@nl

type

label

New technologies in using recombinant attenuated Salmonella vaccine vectors.

@en

New technologies in using recombinant attenuated Salmonella vaccine vectors.

@nl

prefLabel

New technologies in using recombinant attenuated Salmonella vaccine vectors.

@en

New technologies in using recombinant attenuated Salmonella vaccine vectors.

@nl

P1433

Q37674803-B3D318F0-1C2F-437F-B507-739C463D03FA

P1476

Q37674803-AFC153C4-4DFE-4C83-9E14-F854D9D2650A

P2093

Q37674803-1273230E-949B-492B-B585-79D590EEAB4D

Q37674803-5D33E4B2-0EDD-4EDF-8407-F974D73591B2

Q37674803-62C7A4FD-B36E-4150-9D45-A9DB02F3ED03

Q37674803-6ABC4EAE-EBCF-4847-8413-E2E86C9F85D7

Q37674803-7BFE7742-3F95-4C3B-90F8-8B69F926E0C8

Q37674803-B0B5119F-19FE-4CA3-9171-799CA4992BD8

Q37674803-E7F9F4B9-3AB1-4194-88CE-663A07D00E2A

P2860

Q37674803-0533F909-7017-4F26-9A79-CBD6FCE2CA41

Q37674803-05BFBD05-D468-4FCC-AF9C-DED3F8720183

Q37674803-05F2F89E-967C-4CA6-B06D-91670E0C8681

Q37674803-0616C14A-3C3F-4663-B604-FB636A7C3C53

Q37674803-12B92FCB-D894-4D68-999F-27C13686CD81

Q37674803-1880F848-040A-45F9-8FA3-79E4B3577231

Q37674803-1B75E22A-34EF-4C4C-BE55-E6C34DCFA65D

Q37674803-1D053AB2-313A-4303-9750-31BD3DE5BF58

Q37674803-1E7FAB97-3A7E-4B1E-A594-94EC23BFDEA6

Q37674803-2105040C-085E-4D15-8101-C33698B1E95C

P304

Q37674803-396B383D-89BB-4DE3-A1AB-9522339C78D9

P31

Q37674803-B274E2EC-2812-424D-AF15-4DF73110A953

P356

Q37674803-8EFEF88A-BE8A-4495-9910-C466F43ADE99

P433

Q37674803-314A5799-2D95-4DE2-9FBF-1DD6DE764857

P478

Q37674803-51095AAE-5540-4C8E-B7E2-36EABC2CA3BE

P577

Q37674803-B3190BAA-BC1D-46EF-9A2F-3C96E1C1AE0D

P698

Q37674803-C8C86AF5-2AA9-4512-B178-03450A174E3F

P921

Q37674803-EC27AEF7-2BE9-4CE9-BED4-350340D7528C

P932

Q37674803-0E2DF776-A125-4740-8B22-F99AFF3CEACE

P356

CRITREVIMMUNOL.V30.I3.30

P1433

Critical Reviews in Immunology

P1476

New technologies in using recombinant attenuated Salmonella vaccine vectors.

@en

P2093

Bronwyn Gunn

http://www.w3.org/2001/XMLSchema#string

Roy Curtiss

http://www.w3.org/2001/XMLSchema#string

Shifeng Wang

http://www.w3.org/2001/XMLSchema#string

Soo-Young Wanda

http://www.w3.org/2001/XMLSchema#string

Wei Kong

http://www.w3.org/2001/XMLSchema#string

Wei Xin

http://www.w3.org/2001/XMLSchema#string

Yuhua Li

http://www.w3.org/2001/XMLSchema#string

P2860

Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter

Resistance to host antimicrobial peptides is necessary for Salmonella virulence

Codon bias at the 3'-side of the initiation codon is correlated with translation initiation efficiency in Escherichia coli.

Optimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters.

Activation of ara operons by a truncated AraC protein does not require inducer

The epidemiology of pneumococcal infection in children in the developing world.

Innate immunity mediated by MyD88 signal is not essential for induction of lipopolysaccharide-specific B cell responses but is indispensable for protection against Salmonella enterica serovar Typhimurium infection.

MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen.

Salmonella interactions with host cells: in vitro to in vivo.

Codon bias and heterologous protein expression.

P304

255-270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1615/CRITREVIMMUNOL.V30.I3.30

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20370633

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

P932

3970581

http://www.w3.org/2001/XMLSchema#string